Besides PAX6, we assessed the levels of other neural markers (Nestin, SOX1) and found no significant differences in their induction at the early NPC stage (Fig. 3c and Supplementary Fig. 2). The gene discussed is SOX1; the disease is nasopharyngeal carcinoma.